Zhejiang Medicine Co., Ltd. (SHA:600216)
China
· Delayed Price · Currency is CNY 14.70
+0.09 (0.62%)
Apr 29, 2026, 3:00 PM CST
Zhejiang Medicine Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 13,849 | 13,138 | 15,252 | 10,281 | 11,203 | 16,368 | Upgrade
|
| Market Cap Growth | 7.31% | -13.86% | 48.35% | -8.23% | -31.56% | 25.59% | Upgrade
|
| Enterprise Value | 11,691 | 11,060 | 14,305 | 9,752 | 10,751 | 15,886 | Upgrade
|
| Last Close Price | 14.61 | 13.86 | 15.48 | 10.33 | 11.09 | 15.83 | Upgrade
|
| PE Ratio | 18.70 | 15.04 | 13.14 | 23.93 | 20.76 | 15.66 | Upgrade
|
| Forward PE | 12.37 | 13.46 | 10.55 | 13.58 | 15.18 | 12.31 | Upgrade
|
| PS Ratio | 1.57 | 1.48 | 1.63 | 1.32 | 1.38 | 1.79 | Upgrade
|
| PB Ratio | 1.22 | 1.19 | 1.40 | 1.03 | 1.15 | 1.78 | Upgrade
|
| P/TBV Ratio | 1.30 | 1.27 | 1.53 | 1.16 | 1.32 | 2.04 | Upgrade
|
| P/FCF Ratio | 11.47 | 9.13 | 28.55 | - | - | 83.06 | Upgrade
|
| P/OCF Ratio | 8.24 | 6.97 | 12.47 | 16.21 | 21.52 | 14.40 | Upgrade
|
| EV/Sales Ratio | 1.33 | 1.25 | 1.53 | 1.25 | 1.33 | 1.74 | Upgrade
|
| EV/EBITDA Ratio | 8.04 | 7.05 | 7.11 | 13.32 | 9.19 | 9.09 | Upgrade
|
| EV/EBIT Ratio | 15.68 | 12.87 | 11.09 | 1222.28 | 21.95 | 13.69 | Upgrade
|
| EV/FCF Ratio | 9.68 | 7.68 | 26.78 | - | - | 80.62 | Upgrade
|
| Debt / Equity Ratio | 0.08 | 0.08 | 0.07 | 0.08 | 0.09 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | 0.66 | 0.56 | 0.38 | 1.10 | 0.71 | 0.27 | Upgrade
|
| Debt / FCF Ratio | 0.79 | 0.61 | 1.42 | - | - | 2.42 | Upgrade
|
| Net Debt / Equity Ratio | -0.20 | -0.23 | -0.14 | -0.10 | -0.11 | -0.19 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.57 | -1.62 | -0.75 | -1.34 | -0.90 | -1.00 | Upgrade
|
| Net Debt / FCF Ratio | -1.89 | -1.77 | -2.82 | 6.02 | 2.31 | -8.88 | Upgrade
|
| Asset Turnover | 0.63 | 0.64 | 0.71 | 0.62 | 0.65 | 0.79 | Upgrade
|
| Inventory Turnover | 3.20 | 3.00 | 2.70 | 2.69 | 2.81 | 3.30 | Upgrade
|
| Quick Ratio | 2.44 | 2.13 | 1.67 | 1.39 | 1.40 | 1.30 | Upgrade
|
| Current Ratio | 3.39 | 2.96 | 2.56 | 2.26 | 2.29 | 2.00 | Upgrade
|
| Return on Equity (ROE) | 5.60% | 6.93% | 9.79% | 2.81% | 3.84% | 10.28% | Upgrade
|
| Return on Assets (ROA) | 3.31% | 3.85% | 6.07% | 0.04% | 2.45% | 6.30% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.66% | 7.67% | 11.82% | 0.07% | 4.49% | 12.30% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.20% | 7.40% | 11.50% | 0.10% | 4.90% | 12.20% | Upgrade
|
| Earnings Yield | 5.42% | 6.65% | 7.61% | 4.18% | 4.82% | 6.39% | Upgrade
|
| FCF Yield | 8.72% | 10.96% | 3.50% | -1.58% | -4.06% | 1.20% | Upgrade
|
| Dividend Yield | 1.92% | 2.02% | 2.39% | 1.45% | 1.53% | 2.08% | Upgrade
|
| Payout Ratio | 50.00% | 43.13% | 14.67% | 44.67% | 65.07% | 24.88% | Upgrade
|
| Buyback Yield / Dilution | -0.91% | 0.42% | -0.46% | 0.91% | -0.47% | -0.26% | Upgrade
|
| Total Shareholder Return | 1.01% | 2.44% | 1.93% | 2.36% | 1.06% | 1.83% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.